T cell costimulation by the TNF ligand BAFF

被引:192
作者
Huard, B
Schneider, P
Mauri, D
Tschopp, J
French, LE
机构
[1] Univ Geneva, Med Ctr, Dermatol Lab, CH-1211 Geneva 4, Switzerland
[2] Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland
[3] Apotech Biochem, Epalinges, Switzerland
关键词
D O I
10.4049/jimmunol.167.11.6225
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The TNF ligand family member B cell-activating factor belonging to TNF family (BAFF, also called Blys, TALL-1, zTNF-4, or THANK) is an important survival factor for B cells. In this study, we show that BAFF is able to regulate T cell activation. rBAFF induced responses (thymidine incorporation and cytokine secretion) of T cells, suboptimally stimulated through their TCR. BAFF activity was observed on naive, as well as on effector/memory T cells (both CD4(+) and CD8(+) subsets), indicating that BAFF has a wide function on T cell responses. Analysis of the signal transduced by BAFF into T cells shows that BAFF has no obvious effect on T cell survival upon activation, but is able to deliver a complete costimulation signal into T cells. Indeed, BAFF is sufficient to induce IL-2 secretion and T cell division, when added to an anti-TCR stimulation. This highlights some differences in the BAFF signaling pathway in T and B cells. In conclusion, our results indicate that BAFF may play a role in the development of T cell responses, in addition to its role in B cell homeostasis.
引用
收藏
页码:6225 / 6231
页数:7
相关论文
共 31 条
  • [1] BAFF mediates survival of peripheral immature B lymphocytes
    Batten, M
    Groom, J
    Cachero, TG
    Qian, F
    Schneider, P
    Tschopp, J
    Browning, JL
    Mackay, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) : 1453 - 1465
  • [2] Co-stimulation in T cell responses
    Chambers, CA
    Allison, JP
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (03) : 396 - 404
  • [3] Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response
    Do, RKG
    Hatada, E
    Lee, H
    Tourigny, MR
    Hilbert, D
    Chen-Kiang, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) : 953 - 964
  • [4] APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth
    Hahne, M
    Kataoka, T
    Schröter, M
    Hofmann, K
    Irmler, M
    Bodmer, JL
    Schneider, P
    Bornard, T
    Holler, N
    French, LE
    Sordat, B
    Rimoldi, D
    Tschopp, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (06) : 1185 - 1190
  • [5] Harrop JA, 1998, J IMMUNOL, V161, P1786
  • [6] CD4/MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II INTERACTION ANALYZED WITH CD4 AND LYMPHOCYTE-ACTIVATION GENE-3 (LAG-3)-IG FUSION PROTEINS
    HUARD, B
    PRIGENT, P
    TOURNIER, M
    BRUNIQUEL, D
    TRIEBEL, F
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) : 2718 - 2721
  • [7] Kelly K, 2000, CANCER RES, V60, P1021
  • [8] Caspase activation is required for T cell proliferation
    Kennedy, NJ
    Kataoka, T
    Tschopp, J
    Budd, RC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12) : 1891 - 1895
  • [9] THE BCMA GENE, PREFERENTIALLY EXPRESSED DURING B-LYMPHOID MATURATION, IS BIDIRECTIONALLY TRANSCRIBED
    LAABI, Y
    GRAS, MP
    BROUET, JC
    BERGER, R
    LARSEN, CJ
    TSAPIS, A
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (07) : 1147 - 1154
  • [10] Control of lymphocyte function through CD27-CD70 interactions
    Lens, SMA
    Tesselaar, K
    van Oers, MHJ
    van Lier, RAW
    [J]. SEMINARS IN IMMUNOLOGY, 1998, 10 (06) : 491 - 499